InsiderTrades

Form 4 for INSM INSMED Inc

Accepted 2022-07-08 00:00:00 ET · period of report 2022-07-07 · accession 0001402051-22-000002 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2022-07-08 2022-07-07 INSM Lewis William COB, CEO, Dir M - OptEx $16.16 +96.6K 353.3K +38% +$1.56M
D 2022-07-08 2022-07-07 INSM Lewis William COB, CEO, Dir S - Sale+OE $23.00 -96.6K 256.7K -27% -$2.22M
D 2022-07-08 2022-07-07 INSM Lewis William COB, CEO, Dir M - OptEx $0.00 -96.6K 0 -100% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Common Stock 2022-07-07 M A 96,614 $16.16 353,330 D — — (F2) Includes 888 shares acquired through the Company's 2018 Employee Stock Purchase Plan.
2 Common Common Stock 2022-07-07 S D 96,614 $23.00 256,716 D — — (F3) This is the weighted average sales price representing 96,614 shares sold at prices ranging from $23.00 to $23.03 per share. The reporting person undertakes to provide to the SEC staff, the issuer, or a security holder of the issuer the number of shares sold at each price within the price range upon request.
3 Derivative Stock Option (right to buy) 2022-07-07 M D 96,614 $0.00 0 D $16.16 · — to 2026-01-07 96,614 Common Stock (F4) The options became exercisable based on the following vesting schedule: twenty five percent (25%) vested on the first anniversary of the grant date and an additional twelve and one half percent (12.5%) vested on each sixth month anniversary date thereafter through the fourth anniversary of the date of grant.